Registered Trials
-
NCT05508477
Phase 3Indonesia
Total Enrollment: 4,005
Official Trial Registration:
-
NCT05226429
Phase 1/2Indonesia
Total Enrollment: 495
Official Trial Registration:
This site is no longer being updated. Data are accurate as of 2 Dec 2022.
© 2023 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.